Metraipolis › archive › dc_7202be4d5905
Phenotypic Response Surfaces-Guided Optimization (PRS-OPT) of Propolis-Metformin-Regorafenib Combination Therapy for MASLD-Associated Hepatocellular Carcinoma — Europe PMC PMID:42238013
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42238013
- DOI
- 10.32604/or.2026.074145
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T09:29:35.129Z
- SHA-256 of the archived text
8e76593b7f1eee236618aa702df39cd206ab1f447b7fdbbb1dedb511e18a6da5- Stable URL of this page
https://metraipolis.com/documento/dc_7202be4d5905
How to cite
Phenotypic Response Surfaces-Guided Optimization (PRS-OPT) of Propolis-Metformin-Regorafenib Combination Therapy for MASLD-Associated Hepatocellular Carcinoma — Europe PMC PMID:42238013 — Europe PMC (en), https://europepmc.org/article/MED/42238013 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7202be4d5905 (Metraipolis archive dc_7202be4d5905, sha256 8e76593b7f1eee236618aa702df39cd206ab1f447b7fdbbb1dedb511e18a6da5)
BibTeX
@misc{dc7202be4d5905,
title = {Phenotypic Response Surfaces-Guided Optimization (PRS-OPT) of Propolis-Metformin-Regorafenib Combination Therapy for MASLD-Associated Hepatocellular Carcinoma — Europe PMC PMID:42238013},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42238013},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7202be4d5905; sha256 8e76593b7f1eee236618aa702df39cd206ab1f447b7fdbbb1dedb511e18a6da5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42238013. Agents can read the archived copy with the MCP tool read_document.